These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12946790)

  • 21. Barrett's esophagus: management of high-grade dysplasia and cancer.
    Ruol A; Zaninotto G; Costantini M; Battaglia G; Cagol M; Alfieri R; Epifani M; Ancona E
    J Surg Res; 2004 Mar; 117(1):44-51. PubMed ID: 15013713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.
    Montgomery E; Goldblum JR; Greenson JK; Haber MM; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Washington K; Zahurak ML; Hart J
    Hum Pathol; 2001 Apr; 32(4):379-88. PubMed ID: 11331954
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neodymium:yttrium-aluminum garnet contact laser ablation of Barrett's high grade dysplasia and early adenocarcinoma.
    Weston AP; Sharma P
    Am J Gastroenterol; 2002 Dec; 97(12):2998-3006. PubMed ID: 12492182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.
    Srivastava A; Hornick JL; Li X; Blount PL; Sanchez CA; Cowan DS; Ayub K; Maley CC; Reid BJ; Odze RD
    Am J Gastroenterol; 2007 Mar; 102(3):483-93; quiz 694. PubMed ID: 17338734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia.
    Nguyen NT; Schauer P; Luketich JD
    Surgery; 2000 Mar; 127(3):284-90. PubMed ID: 10715983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical management of high-grade dysplasia in Barrett's esophagus.
    Rice TW; Falk GW; Achkar E; Petras RE
    Am J Gastroenterol; 1993 Nov; 88(11):1832-6. PubMed ID: 8237928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol.
    Kariv R; Plesec TP; Goldblum JR; Bronner M; Oldenburgh M; Rice TW; Falk GW
    Clin Gastroenterol Hepatol; 2009 Jun; 7(6):653-8; quiz 606. PubMed ID: 19264576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Barrett's esophagus with high-grade dysplasia.
    McAllaster JD; Buckles D; Al-Kasspooles M
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):303-16. PubMed ID: 19275509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: a prospective study.
    Conio M; Blanchi S; Lapertosa G; Ferraris R; Sablich R; Marchi S; D'Onofrio V; Lacchin T; Iaquinto G; Missale G; Ravelli P; Cestari R; Benedetti G; Macrì G; Fiocca R; Munizzi F; Filiberti R
    Am J Gastroenterol; 2003 Sep; 98(9):1931-9. PubMed ID: 14499768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection.
    Peters F; Kara M; Rosmolen W; Aalders M; Ten Kate F; Krishnadath K; van Lanschot J; Fockens P; Bergman J
    Endoscopy; 2005 May; 37(5):418-24. PubMed ID: 15844019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia.
    Overholt BF; Wang KK; Burdick JS; Lightdale CJ; Kimmey M; Nava HR; Sivak MV; Nishioka N; Barr H; Marcon N; Pedrosa M; Bronner MP; Grace M; Depot M;
    Gastrointest Endosc; 2007 Sep; 66(3):460-8. PubMed ID: 17643436
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus.
    Sharma P; Falk GW; Weston AP; Reker D; Johnston M; Sampliner RE
    Clin Gastroenterol Hepatol; 2006 May; 4(5):566-72. PubMed ID: 16630761
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression.
    Weston AP; Banerjee SK; Sharma P; Tran TM; Richards R; Cherian R
    Am J Gastroenterol; 2001 May; 96(5):1355-62. PubMed ID: 11374668
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia.
    Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW
    Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients.
    Giovannini M; Bories E; Pesenti C; Moutardier V; Monges G; Danisi C; Lelong B; Delpero JR
    Endoscopy; 2004 Sep; 36(9):782-7. PubMed ID: 15326573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autofluorescence endoscopy in surveillance of Barrett's esophagus: a multicenter randomized trial on diagnostic efficacy.
    Borovicka J; Fischer J; Neuweiler J; Netzer P; Gschossmann J; Ehmann T; Bauerfeind P; Dorta G; Zürcher U; Binek J; Meyenberger C
    Endoscopy; 2006 Sep; 38(9):867-72. PubMed ID: 16981102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy.
    Schembre DB; Huang JL; Lin OS; Cantone N; Low DE
    Gastrointest Endosc; 2008 Apr; 67(4):595-601. PubMed ID: 18279860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Progression from intestinal metaplasia to adenocarcinoma in Barrett s esophagus: usefulness of endoscopic surveillance].
    Burdiles P; Csendes A; Smok G; Braghetto I; Korn O
    Rev Med Chil; 2003 Jun; 131(6):587-96. PubMed ID: 12942585
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-biopsy detection of intestinal metaplasia and dysplasia in Barrett's esophagus: a prospective multicenter study.
    Sharma P; Marcon N; Wani S; Bansal A; Mathur S; Sampliner R; Lightdale C
    Endoscopy; 2006 Dec; 38(12):1206-12. PubMed ID: 17163320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.